A Preview Of Sangamo Therapeutics's Earnings
Portfolio Pulse from Benzinga Insights
Sangamo Therapeutics (NASDAQ:SGMO) is set to release its latest quarterly earnings report on Tuesday, 2023-08-08. Analysts estimate an earnings per share (EPS) of $-0.34. The company's past performance shows a mixed impact on the share price post-earnings release. The company's shares were trading at $1.18 as of August 04, with a 77.77% decrease over the last 52-week period.
August 07, 2023 | 7:01 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Sangamo Therapeutics is expected to report an EPS of $-0.34 in its upcoming earnings. The company's stock price has seen a significant decrease of 77.77% over the last 52 weeks.
The company's stock price has been on a downward trend over the past year, which could be a cause for concern for investors. The upcoming earnings report, particularly any guidance provided, could significantly impact the stock's short-term performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100